A mouse model of angiotensin II slow pressor response: Role of oxidative stress

Journal of the American Society of Nephrology

Volumn 13, Issue 12, 2002, Pages 2860-2868

  Kawada, Noritaka ^a,b   Imai, Enyu ^b   Karber, Alexsander ^a   Welch, William J ^a   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANGIOTENSIN; ELECTROLYTE; SUPEROXIDE DISMUTASE; TEMPOL; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; AMINE OXIDE; ANGIOTENSIN II; ANTIOXIDANT; DRUG DERIVATIVE; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN F2 ALPHA; VASOCONSTRICTOR AGENT;

ARTICLE; BODY WEIGHT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; ELECTROLYTE BLOOD LEVEL; EXPERIMENTAL MODEL; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEART RATE; HEMATOCRIT; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRESSOR RESPONSE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; URINE VOLUME; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; INFUSION PUMP; KIDNEY; PHYSIOLOGY; SPIN LABELING; SYSTOLE; URINE;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CYCLIC N-OXIDES; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; F2-ISOPROSTANES; INFUSION PUMPS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; SPIN LABELS; SYSTOLE; VASOCONSTRICTOR AGENTS;

EID: 1842845250     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000035087.11758.ED     Document Type: Article

References (50)

1. Dickinson CJ, Lawrence JR: A slowly developing pressor response to small concentration of angiotensin. Lancet 1: 1354-1356 1963
2. Brown A, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ: Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol 241: H381-H388, 1981
3. Romero JC, Reckelhoff JF: Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34: 943-949, 1999
4. Granger JP, Schnackenberg CG: Renal mechanisms of angiotensin II-induced hypertension. Sem Nephrol 20: 417-425, 2000
5. Lever AF: The fast and the slowly developing pressor effects of angiotensin II. In: The Renin-Angiotensin System, edited by Robertson JIS, Nicholls MG, London, Gower Medical Publishing, 1993, pp 28.1-28.9
6. Bean BL, Brown JJ, Casals-Stenzel J, Frasher R, Lever AF, Millar JA, Morton JJ, Petch B, Riegger AJG, Robertson JIS: The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Rec 44: 452-458, 1979
7. Welch WJ, Ahlstrom NG, Wilcox CS: Mechanism of hypertension during prolonged infusion of thromboxane mimetic. Europ J Int Med. 2: 277-280, 1992
8. Gao H, Welch WJ, Dibona GF, Wilcox CS: Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats. Am J Physiol. 273: H734-H739, 1997
9. Wilcox CS, Cardozo J, Welch WJ: AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K, 1C Goldbatt hypertension in the rat. Am J Physiol. 271: R891-R896, 1996
10. Fitzgerald SM, Stevenson KM, Evans RG Anderson WP: Systemic hemodynamic response to chronic angiotensin II infusion into the renal artery of dogs. Am J Physiol 273: R1980-R1989, 1997
11. Cervenka L, Kramer HJ, Maly J, Heller J: Role of nNOS in regulation of renal function in angiotensin II-induced hypertension. Hypertension 38: 280-285, 2001
12. Laursen J, Rajagopalan S, Galis Z, Tarpey M, Freeman B, Harrison DG: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-595, 1997
13. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996
14. Haas JA, Kreiger JD, Boltermann R, Juncos LA, Romero JC: Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension 34: 983-986, 1999
15. Reckelhoff J, Zhang H, Srivastava K, Roberts LJ II, Morrow JD, Romero JC: Subpressor doses of Ang II increase plasma F2- isoprostanes in rats. Hypertension 35: 476-479, 2000
16. Ortiz MC, Sanabria E, Manriquez MC, Romero JC, Juncos LA: Role of endothelin and isoprostanes in slow pressor response to angiotensin II. Hypertension 37: 505-510, 2001
17. Ortiz MC, Manriquez MC, Romero JC, Juncos LA: Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 38: 655-659, 2001
18. Cosentino F, Sill JC, Katusic ZS: Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 23: 229-235, 1994
19. Chin SY, Wang CT, Majid DSA, Navar LG: Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat. Am J Physiol 274: F876-F882, 1998
20. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T: Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26: 854-857, 1995
21. Deng X, Welch WJ, Wilcox CS: Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension 27: 1173-1179, 1996
22. ·- and NO. Am J Physiol 279: F302-F308, 2000
23. Deng X, Welch WJ, Wilcox CS: Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension 27: 1173-1179, 1996
24. Cervenka L, Maly J, Karasova L, Simova M, Vitko S, Hellerova S, Heller J, El-Dahr SS. Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice. Hypertension 37: 967-973, 2001
25. Cifuentes ME, Rey FE, Carretero OA, Pagano PJ: Upregulation of p67phox and gp91phox in aortas from angiotensin II-infused mice. Am J Physiol 279: H2234-H2240, 2000
26. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T: Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 104: 346-351, 2001
27. Weiss D, Kools JJ, Taylor WR: Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 103: 448-454, 2001
28. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ: A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387, 1990
29. Lawson JA, Rokach J, FitzGerald GA. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 274: 24441-24444, 1999
30. Iannone A, Bini A, Swartz HM, Tomasi A, Vannini V: Metabolism in rat liver microsomes of the nitroxide spin probe tempol. Biochem Pharm 38: 2581-2586, 1989
31. Nilsson UA, Olsson LI, Carlin G, Bylund-Fellenius AC: Inhibition of lipid peroxidation by spin labels: Relationships between structure and function. J Biol Chem 19: 11131-11135, 1989
32. 2. Hypertension 33: 424-428, 1999
33. Wilcox CS, Welch WJ, Snellen H: Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int 40: 1090-1097, 1991
34. Riemenshneider T, Bohle A: Morphologic aspects of low-potassium and low-sodium nephropathy. Clin Nephrol 19: 271-279, 1983
35. Muehrcke RC, Rosen S: Hypokalemic nephropathy in rat and man. A light and electron microscopic study. Lab Invest 13: 1359-1373, 1964
36. Krishna GG: Hypokalemic states: Current clinical issues. Semin Nephrol 10: 515-524, 1990
37. Suga S, Phillips MI, Ray PE, Raleigh JA, Vio CP, Kim YG, Mazzali M, Gordon KL, Hughes J, Johnson RJ: Hypokalemia induced renal injury and alterations in vasoactive mediators that favor salt sensitivity. Am J Physiol 281: F620-F629, 2001
38. Stevenson KM, Edgley AJ, Bergstrom G, Worthy K, Kett MM, Anderson WP: Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension. Hypertension 36: 839-844, 2000
39. Yura T, Fukunaga M, Khan R, Nassar GN, Badr KF, Montero A: Free radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression in endothelial cells. Kidney Int 56: 471-478, 1999
40. Zeltcer G, Berenshtein E, Samuni A, Chevion M: Nitroxide radicals prevent metal-aggravated reperfusion injury in isolated rat heart. Free Radic Res 27: 627-635, 1997
41. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C: Tempol, a membrane permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in rat. Kidney Int 58: 658-673, 2000
42. Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, Russo A: Tempol, a stable free radical, is a novel radiation protector. Cancer Res 52: 1750-1753, 1992
43. Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, Russo A: Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimetic, tempol. Arch Biochem Biophys 289: 62-70, 1991
44. Schnackenberg CG, Wilcox CS: The SOD mimetic tempol restores vasodilatation in afferent arterioles of experimental diabetes. Kidney Int 59: 1859-1864, 2001
45. Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Hypertension 32: 59-64, 1998
46. Dobrian AD, Schriver SD, Prewitt RL: Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 38: 361-366, 2001
47. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS: Expression and cellular localization of classic NADPH oxidase subunits in the kidney. Hypertension 39: 269-274, 2002
48. Welch WJ, Wilcox CS: AT1 receptor antagonist combats oxidative stress and restores nitric oxide. Kidney Int 59: 1257-1263, 2001
49. Welch WJ, Tojo A, Wilcox CS: Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol 278: F769-F776, 2000
50. Wilcox CS, Welch WJ: Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol Scand 168: 119-124, 2000